An Almac bioinformatics team will interrogate the resulting data to recognize any potential signature. Our research will use the Breast Cancer DSA microarray to examine the transcriptome of ductal carcinoma in situ at a larger degree of specificity generating more information that can help us pull meaningful conclusions from our data. Eventually we desire to create a gene expression signature that may inform clinical treatment strategies stated Prof Adrian Harris, Cancer Analysis UK Professor of Medical Oncology in the University of Principal and Oxford Investigator on the analysis.Performed its 2,000th kidney transplant in 1999. Developed molecular method to detect kidney transplant rejection in 2001. The comprehensive kidney disease program at NewYork-Presbyterian Medical center – – including NewYork-Presbyterian/Weill Cornell and NewYork-Presbyterian Medical center/Columbia – – was rated second in the nation by U.S.Information & World Statement in its 2007 America’s Best Hospitals concern. To learn more, patients may call NYP-NEWS. NewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in NEW YORK, is among the leading academic medical centers in the globe, comprising the teaching medical center NewYork-Presbyterian and its educational partner, Weill Cornell Medical University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in every areas of medicine, and is committed to excellence in patient care, research, education and community service.